oh, by the way, info on 5 major psychiatric disorders

Five major psychiatric disorders have overlapping patterns of genetic
activity, new study shows
By Amy Ellis Nutt February 8 at 5:34 PM Email the author

Artist's conception of a network of brain cells. Researchers have found
similar signs of disrupted neuronal communication in five psychiatric
disorders. (iStock)
This post has been updated.

Certain patterns of genetic activity appear to be common among five
distinct psychiatric disorders — autism, schizophrenia, bipolar
disorder, depression and alcoholism — according to a new study. The
paper, appearing in the journal Science, was released Thursday.

Scientists analyzed data from 700 human brains, all donated either from
patients who suffered one of these major psychiatric disorders or from
people who had not been diagnosed with mental illness. The scientists
found similar levels of particular molecules in the brains of people
with autism, schizophrenia and bipolar disorder; other commonalities
between bipolar and major depression; and other matches between major
depression and alcoholism.

“We’re on the threshold to using genomics and molecular technology to
look at [mental illness] in a way we’ve never been able to do before,�
said Daniel Geschwind, a neurogeneticist at the University of California
at Los Angeles and a leader of the study. “Psychiatric disorders have no
obvious pathology in the brain, but now we have the genomic tools to ask
what actually goes awry in these brains.�

ADVERTISING

These shared, disease-related “signatures� involve a disruption in how
brain cells communicate with one another.

“What we're seeing is giving us a sense of alterations in the way
neurons are signaling to each other,� Geschwind said. “We think some of
it is confused activity. That’s the next step, to connect it to the
physiology: how do these changes affect neuronal firing and
connectivity. We have a clue that it’s adding 'noise' to the system.
Maybe things are attenuated or jumbled.�

To eliminate the possibility that antipsychotic medication — likely to
have been taken by many of the deceased mentally ill subjects — was
causing the overlapping patterns of molecules in the brains, the
researchers compared the brain samples of their subjects with those
taken from nonhuman primates that were first given PCP to evoke
psychosis, then treated with antipsychotic drugs. The medications
appeared to partially “normalize� the disordered genetic activity in the
monkey's brains.

2:34
The genetics of autism, explained
Embed
Share
Here's what you need to know about genetics and autism. (Animation and
illustration by Marc Christofordis for Spectrum)

“Gene-expression patterns might someday be good targets for reversal by
medication,� Geschwind said. “In [our study] the drugs at least
partially normalized gene expression in the brain.�

Many studies have identified variations in the genetic code that seem to
be more common in people with psychiatric disorders. This approach goes
a step further to show how genes are more or less active in the brains
of people with various conditions. The study confirmed that genetic
variations contributed to the patterns of activity in the brains, but as
the authors wrote, “there is undoubtedly a contribution from
environmental effects.�


Psychiatric disorders have some overlapping symptoms, making them
difficult to diagnose. The molecular signatures in the new study
suggested that schizophrenia, bipolar disorder and autism have
dysfunctional synapses, the points of contact between neurons where they
exchange information. Brain support cells called microglia and astroglia
had unusual patterns of activity in some of the disorders, as well.

Geschwind credits not only technological advances for the breakthrough
but also an extraordinary level of international collaboration made
possible by the National Institutes of Health's PsychEncode consortium,
which encourages the sharing of information. The drop in cost of
sequencing genetic code has also helped.

What the research represents, Geschwind said, is the chance to get
closer to targeted molecular therapy, much like what's being done with
cancer. “This gives us the first road map to what’s really going on with
these disorders.�

Thomas Lehner, director of the Office of Genomics Research Coordination
at the National Institute of Mental Health, called it a “very exciting
finding� with the potential “to give us a better understanding of the
molecular machinery of neuropsychiatric disorders.�


Carol Tamminga, the chair of psychiatry at the University of Texas
Southwestern’s O’Donnell Brain Institute, goes further. She thinks the
new study will require revising how psychiatric diagnoses are made. In
the past, those were derived solely by observing patients and cataloging
symptoms.

“Now we can go back to the drawing board and decide what are the
biological characteristics than can define these diseases,� she said.
“This gives us guidance as to what direction to take.�

Read mo

https://www.washingtonpost.com/news/...=.d84f32a09e2c